The Ozempic gallbladder lawsuit is one of the biggest pharmaceutical legal battles heading into 2026. Thousands of patients claim the popular diabetes and weight loss drug caused serious gallbladder injuries that Novo Nordisk failed to warn them about.
If you took Ozempic and ended up with gallstones, gallbladder disease, or emergency gallbladder surgery, you may be entitled to compensation. The lawsuits are moving through federal court, and 2026 is expected to bring the first bellwether trials.
This article breaks down everything you need to know. You will find settlement estimates, eligibility rules, filing deadlines, and a full timeline of where this litigation stands right now.
Here is one number worth knowing: the FDA’s adverse event database logged over 10,000 gallbladder-related reports tied to GLP-1 drugs like Ozempic through early 2025.
What Is the Ozempic Gallbladder Lawsuit About?
The Ozempic gallbladder lawsuit is a mass tort action against Novo Nordisk, the Danish pharmaceutical company that manufactures Ozempic. Plaintiffs allege the drugmaker knew or should have known that semaglutide, the active ingredient in Ozempic, carries a significant risk of gallbladder disease.
The core legal argument is “failure to warn.” Patients say that Novo Nordisk did not adequately disclose the risk of gallstones, acute cholecystitis, and other gallbladder conditions on the drug’s label. Many of these patients ended up in emergency rooms.
Some needed their gallbladders surgically removed. Others suffered bile duct injuries that required extended hospital stays. A number of claimants report lasting digestive problems even after surgery.
Think of it this way: if a car manufacturer knew the brakes could fail under certain conditions and said nothing, they would be liable. That is essentially the argument being made against Novo Nordisk.
| Key Detail | Information |
|---|---|
| Defendant | Novo Nordisk |
| Drug | Ozempic (semaglutide) |
| Primary Allegation | Failure to warn about gallbladder risks |
| Injury Types | Gallstones, cholecystitis, gallbladder removal, bile duct injury |
| Case Type | Mass tort / MDL |
Ozempic Gallbladder Lawsuit Update for 2026
As of early 2026, the Ozempic gallbladder litigation has entered a critical phase. The multidistrict litigation (MDL) consolidated in the Eastern District of Pennsylvania continues to grow, with new cases being added monthly.
Bellwether trial selections are expected to be finalized by mid-2026. These are the test cases that will go to trial first, and their outcomes will heavily influence settlement negotiations for everyone else in the MDL.
Discovery is ongoing. Plaintiffs’ attorneys have been gathering internal Novo Nordisk documents, including clinical trial data, internal safety memos, and marketing communications. Some of this evidence has reportedly shown that the company had early data suggesting gallbladder risks.
The judge overseeing the MDL has set several key deadlines for 2026. Expert witness reports, Daubert challenges, and pretrial motions are all on the calendar.
- Q1 2026: Final bellwether case selections
- Q2 2026: Expert report deadlines
- Q3 2026: Pretrial motions and Daubert hearings
- Q4 2026: Possible first bellwether trial date
If bellwether trials go well for plaintiffs, mass settlement talks could begin as early as late 2026 or early 2027.
How Ozempic Lawsuits Target Gallbladder Injuries
Ozempic lawsuits targeting gallbladder injuries focus on the drug’s effect on bile production and gallbladder motility. Semaglutide is a GLP-1 receptor agonist, and this class of drugs is known to slow down gastric emptying. That slowdown does not just affect the stomach.
The gallbladder contracts to release bile when you eat. GLP-1 drugs suppress that contraction. When the gallbladder does not empty properly, bile sits and concentrates, forming cholesterol crystals that become gallstones.
Published research in medical journals has shown that rapid weight loss itself is a gallstone risk factor. Ozempic causes significant weight loss in many patients. So the drug hits the gallbladder from two angles: chemical suppression and rapid weight change.
Plaintiffs argue that Novo Nordisk understood this mechanism. Clinical trial data from semaglutide studies reportedly showed elevated rates of gallbladder adverse events compared to placebo groups.
Quick Facts:
- GLP-1 drugs reduce gallbladder motility by up to 50% in some studies
- Rapid weight loss increases gallstone risk by 30% to 40%
- Semaglutide clinical trials flagged gallbladder events at higher rates than placebo
Key Takeaway: The Ozempic gallbladder lawsuit centers on Novo Nordisk’s alleged failure to warn patients about a known and scientifically documented risk of gallbladder disease caused by semaglutide.
Ozempic Gallbladder Lawsuit Settlement Amounts
No settlements have been finalized in the Ozempic gallbladder lawsuit as of early 2026, but legal analysts and attorneys handling these cases have published estimated ranges. Individual settlement amounts will vary based on injury severity, medical costs, and the strength of each case.
Attorneys familiar with the litigation have projected settlement tiers based on similar pharmaceutical mass tort outcomes. The Vioxx and Zantac litigations are commonly used as reference points for estimating GLP-1 drug settlements.
Cases involving gallbladder removal surgery with complications are expected to command the highest payouts. Cases involving gallstones that resolved with medication alone will likely fall on the lower end.
| Injury Level | Estimated Settlement Range |
|---|---|
| Gallstones treated with medication | $30,000 to $75,000 |
| Gallbladder removal (uncomplicated) | $100,000 to $250,000 |
| Gallbladder removal with complications | $250,000 to $500,000 |
| Bile duct injury or organ damage | $500,000 to $1,000,000+ |
These are projections, not guarantees. The actual settlement fund and per-person payouts will depend on bellwether trial results and Novo Nordisk’s willingness to negotiate.
Several plaintiff law firms have indicated they expect total litigation value to reach billions of dollars across all GLP-1 related claims.
Who Qualifies for the Ozempic Gallbladder Lawsuit?
You may qualify for the Ozempic gallbladder lawsuit if you took Ozempic and were later diagnosed with a gallbladder condition. The key is proving a link between your Ozempic use and your gallbladder injury through medical records.
Not every Ozempic user qualifies. You need a documented gallbladder diagnosis that occurred after you started taking the drug. People who had gallbladder problems before using Ozempic generally do not qualify unless Ozempic worsened their condition.
Here are the basic eligibility criteria most law firms are using:
- You were prescribed Ozempic (or another semaglutide product like Wegovy)
- You took the drug for any period of time
- You were diagnosed with gallstones, cholecystitis, or gallbladder disease after starting the drug
- You underwent gallbladder removal surgery (cholecystectomy)
- You suffered bile duct injury or other biliary complications
- You have medical records documenting both the prescription and the diagnosis
If you had your gallbladder removed before ever taking Ozempic, you likely do not have a viable claim. However, if you experienced bile duct complications after taking the drug, that could still qualify.
Ozempic Gallbladder Side Effects Linked to Lawsuits
The Ozempic gallbladder side effects driving these lawsuits are serious medical conditions, not minor discomfort. The most common gallbladder side effect reported is cholelithiasis, which is the medical term for gallstones.
Gallstones can block the bile duct and cause intense abdominal pain, nausea, and vomiting. When a gallstone gets stuck, it can trigger acute cholecystitis, an inflammation of the gallbladder that often requires emergency surgery.
The FDA’s adverse event reporting system (FAERS) has recorded thousands of gallbladder-related events linked to semaglutide products. These reports come from patients, doctors, and pharmacists across the country.
Gallbladder side effects cited in lawsuits include:
- Cholelithiasis (gallstones)
- Acute cholecystitis (gallbladder inflammation)
- Cholecystitis (chronic gallbladder inflammation)
- Biliary colic (severe pain from bile duct blockage)
- Cholangitis (bile duct infection)
- Biliary pancreatitis (pancreatitis caused by gallstones)
Many patients report that their doctors never warned them about gallbladder risks when prescribing Ozempic. That gap between the known risk and the lack of patient communication is at the heart of every lawsuit.
Key Takeaway: Ozempic’s gallbladder side effects range from painful gallstones to emergency surgery, and the lawsuits allege Novo Nordisk failed to ensure patients and doctors understood these risks.
Common Ozempic Gallbladder Problems Reported
The most commonly reported Ozempic gallbladder problems are gallstones and gallbladder inflammation. These are not rare occurrences. Clinical trial data and post-market surveillance both show elevated rates of gallbladder events in semaglutide users.
Patients describe symptoms that often start within the first six months of taking Ozempic. Upper right abdominal pain after eating is the most frequent early symptom. Some patients mistake it for heartburn or stomach issues.
As the condition progresses, pain becomes more intense and constant. Fever, jaundice, and severe nausea are signs that the gallbladder is seriously inflamed or that a gallstone has blocked the bile duct.
| Symptom | What It Might Indicate |
|---|---|
| Upper right abdominal pain after meals | Gallstones |
| Persistent nausea and vomiting | Cholecystitis |
| Fever with abdominal pain | Gallbladder infection |
| Yellowing of skin or eyes (jaundice) | Bile duct blockage |
| Pain radiating to the right shoulder | Acute cholecystitis |
| Clay-colored stools | Bile flow obstruction |
If you experienced any of these symptoms while taking Ozempic, your medical records from that period are critical evidence for a potential claim.
Ozempic Gallbladder Removal Lawsuit Claims
Ozempic gallbladder removal lawsuits represent the strongest and highest-value claims in this litigation. Patients who underwent a cholecystectomy (gallbladder removal surgery) after taking Ozempic have the clearest case for significant compensation.
Removing the gallbladder is not a minor procedure. While laparoscopic cholecystectomy is common, it still involves general anesthesia, surgical risks, and a recovery period. Some patients experience complications during or after surgery, including bile duct injury, infection, or internal bleeding.
Even without complications, living without a gallbladder changes your digestive system permanently. Many patients deal with chronic diarrhea, difficulty digesting fatty foods, and ongoing discomfort for years after surgery.
The argument in these lawsuits is straightforward. These patients would still have their gallbladders if Novo Nordisk had properly warned them about the risk. By failing to disclose, the company took away their ability to make an informed choice about their treatment.
What gallbladder removal claimants need to prove:
- They were prescribed and took Ozempic
- They had no prior gallbladder disease
- They developed gallbladder disease after starting Ozempic
- They underwent cholecystectomy as a result
- Medical records connect the timeline
Ozempic Lawsuit Payout Per Person Estimates
The estimated Ozempic lawsuit payout per person depends entirely on the severity of injury and the quality of evidence. No two cases are identical, and payouts will reflect that reality.
Legal experts studying similar pharmaceutical mass torts estimate that the average payout per person could fall between $100,000 and $400,000 for moderate to severe gallbladder injuries. That range accounts for medical expenses, lost wages, pain and suffering, and long-term health impacts.
Think of a payout scale like an insurance claim after a car accident. A fender bender pays less than a totaled vehicle. Similarly, gallstones treated with medication pay less than emergency gallbladder surgery with complications.
| Case Strength | Estimated Payout Per Person |
|---|---|
| Weak (minimal documentation) | $10,000 to $30,000 |
| Moderate (gallstones, conservative treatment) | $50,000 to $150,000 |
| Strong (gallbladder removal, clear timeline) | $150,000 to $400,000 |
| Severe (complications, extended hospitalization) | $400,000 to $1,000,000+ |
Attorney fees typically range from 33% to 40% of the settlement amount on a contingency basis. That means no upfront costs for the claimant, but the attorney takes a percentage of the final payout.
Key Takeaway: Individual Ozempic lawsuit payouts per person will range widely, but patients with documented gallbladder surgery and strong medical records can expect the highest compensation.
How to File an Ozempic Gallbladder Lawsuit
Filing an Ozempic gallbladder lawsuit involves several steps, but it is not as complicated as most people fear. The process starts with gathering your medical records and connecting with an attorney experienced in pharmaceutical litigation.
You do not need to pay anything upfront. Nearly every law firm handling these cases works on a contingency fee basis. That means they only get paid if you win or settle.
Step-by-step filing process:
- Gather your medical records. This includes your Ozempic prescription history, pharmacy records, and all medical records related to your gallbladder diagnosis and treatment.
- Document your timeline. Note when you started Ozempic, when symptoms began, and when you received your gallbladder diagnosis or had surgery.
- Contact a qualified attorney. Look for a law firm with experience in mass torts and pharmaceutical litigation. They will evaluate your case for free.
- Case review. The attorney’s team will review your records, assess the strength of your claim, and determine if your case meets the eligibility criteria.
- File the complaint. If your case qualifies, the attorney files a complaint on your behalf. Your case will likely be consolidated into the existing MDL.
- Wait for proceedings. Once filed, your case joins the MDL. You will not need to appear in court unless your case is selected as a bellwether.
The entire process from first call to filing typically takes 4 to 8 weeks.
Ozempic Class Action Lawsuit in 2026
The Ozempic class action lawsuit label is commonly used but slightly misleading. Technically, the Ozempic litigation is a mass tort, not a class action. The difference matters for your payout.
In a class action, everyone in the class gets the same settlement amount. It is one lawsuit with one outcome for all. In a mass tort, each person has their own individual case. Your payout is based on your specific injuries, medical bills, and circumstances.
The Ozempic litigation is structured as an MDL, or multidistrict litigation. All federal cases are consolidated before one judge for pretrial proceedings. This makes the process more efficient without stripping away individual case value.
| Feature | Class Action | Mass Tort (MDL) |
|---|---|---|
| Individual case evaluation | No | Yes |
| Same payout for everyone | Yes | No |
| Your own attorney | Sometimes | Yes |
| Based on your specific injuries | No | Yes |
| Consolidated pretrial proceedings | Sometimes | Yes |
This distinction is good news for Ozempic gallbladder claimants. Your case gets individual attention. If your injuries are severe, your payout reflects that. You are not lumped in with someone who had a mild case of gallstones and took an antacid.
Novo Nordisk Gallbladder Lawsuit Details
Novo Nordisk, the maker of Ozempic, is the primary defendant in these gallbladder lawsuits. The company is a pharmaceutical giant headquartered in Denmark with U.S. operations based in Plainsboro, New Jersey.
Novo Nordisk generated over $35 billion in revenue from semaglutide products in 2024 alone. Ozempic and its weight loss counterpart Wegovy have become two of the best-selling drugs in history. That financial success is central to plaintiffs’ arguments.
Plaintiffs allege that Novo Nordisk prioritized profits over patient safety. Internal documents sought during discovery reportedly show that the company received early signals about gallbladder risks from its own clinical trials but chose not to update its warning label aggressively.
The company’s defense has centered on arguing that gallbladder risks were disclosed in the prescribing information and that the FDA approved the drug’s labeling. Novo Nordisk maintains that Ozempic is safe when used as directed.
Key allegations against Novo Nordisk:
- Failed to adequately warn about gallbladder disease risk
- Minimized gallbladder adverse events in marketing materials
- Did not update warnings promptly after post-market reports
- Promoted Ozempic for weight loss before Wegovy’s approval
- Continued aggressive marketing despite growing safety signals
Key Takeaway: Novo Nordisk faces allegations that it knew about gallbladder risks tied to semaglutide and chose not to adequately warn patients, putting corporate profits above patient safety.
Semaglutide Gallbladder Lawsuit Explained
The semaglutide gallbladder lawsuit encompasses claims against all semaglutide products, not just Ozempic. This includes Wegovy (used for weight management) and Rybelsus (oral semaglutide for diabetes). The active ingredient is the same across all three drugs.
This matters because some patients took Wegovy, not Ozempic, and developed the same gallbladder injuries. Their claims fall under the same MDL. The science linking semaglutide to gallbladder disease does not change based on the brand name.
Semaglutide works by mimicking the GLP-1 hormone. This hormone regulates blood sugar and appetite. It also affects how the gallbladder functions. That is not a side effect that appeared out of nowhere after the drug hit the market.
Published studies in the New England Journal of Medicine and The Lancet flagged gallbladder events during clinical trials for semaglutide. The STEP trials for Wegovy showed gallbladder-related adverse events at rates notably higher than placebo.
| Semaglutide Product | FDA Approval | Primary Use | Gallbladder Claims? |
|---|---|---|---|
| Ozempic | 2017 | Type 2 diabetes | Yes |
| Wegovy | 2021 | Weight management | Yes |
| Rybelsus | 2019 | Type 2 diabetes (oral) | Yes |
If you took any semaglutide product and developed gallbladder problems, you may have a viable claim.
Ozempic Gallstone Lawsuit Claims
Ozempic gallstone lawsuits are a specific subset of the broader gallbladder litigation. Gallstones are the most frequently reported gallbladder injury among Ozempic users, and they range from painless to medical emergencies.
Some gallstones cause no symptoms and are discovered incidentally during imaging. Others cause excruciating pain, block the bile duct, and lead to pancreatitis or infection. The severity of your gallstone condition directly affects the value of your legal claim.
Not all gallstone cases qualify for the lawsuit. Gallstones are common in the general population. To have a viable claim, you need to show that your gallstones developed after you started Ozempic and that you had no prior history of gallstone disease.
Factors that strengthen a gallstone lawsuit claim:
- No history of gallstones before Ozempic
- Gallstones diagnosed within 6 to 18 months of starting the drug
- Required medical intervention (surgery, ERCP, or hospitalization)
- Documented complications from gallstones
- Medical records clearly showing the timeline
Patients who developed gallstones but only needed monitoring or dietary changes will have lower-value claims. Those whose gallstones led to cholecystectomy, pancreatitis, or bile duct injury will pursue significantly higher compensation.
Ozempic Lawsuit Eligibility Requirements
Ozempic lawsuit eligibility comes down to three core factors: you took the drug, you got hurt, and your medical records prove the connection. It sounds simple, but the details matter.
Attorneys screening cases look for a clear chronological link between starting Ozempic and developing gallbladder disease. If you had gallbladder problems before ever touching Ozempic, your case becomes much harder to prove.
Eligibility checklist:
- Took Ozempic, Wegovy, or Rybelsus (any semaglutide product)
- Developed gallbladder disease after starting the medication
- Have medical records showing the Ozempic prescription
- Have medical records documenting gallbladder diagnosis or surgery
- Diagnosis occurred within a reasonable timeframe after starting the drug
- No significant pre-existing gallbladder disease
| Eligibility Factor | Qualifies | Does Not Qualify |
|---|---|---|
| Took Ozempic and got gallstones after | Yes | N/A |
| Had gallbladder removed before Ozempic | N/A | Usually no |
| Took a different GLP-1 drug (not semaglutide) | Separate litigation | Not this MDL |
| Family member took Ozempic (you did not) | N/A | No |
| Gallstones found incidentally, no symptoms | Possibly (weak claim) | N/A |
Key Takeaway: To be eligible for the Ozempic gallbladder lawsuit, you need documented proof that you took semaglutide and developed gallbladder disease afterward, with medical records supporting both facts.
Ozempic Lawsuit Deadline in 2026
The Ozempic lawsuit deadline is governed by the statute of limitations, which varies by state. In most states, you have two to three years from the date you discovered (or should have discovered) that Ozempic caused your gallbladder injury.
This is not measured from when you first took the drug. It is measured from when you knew or reasonably should have known that Ozempic was responsible for your gallbladder condition. That distinction is important because many patients did not connect the two until media coverage increased in 2024 and 2025.
Still, waiting is risky. The longer you wait, the harder it becomes to gather medical records, find treating physicians, and build a strong case. Evidence can be lost. Memories fade. Deadlines can surprise you.
| State Example | Statute of Limitations | Measured From |
|---|---|---|
| California | 2 years | Discovery of injury |
| Texas | 2 years | Date of injury or discovery |
| New York | 3 years | Date of injury |
| Florida | 2 years (as of 2024 reform) | Discovery of injury |
| Pennsylvania | 2 years | Discovery of injury |
If you are reading this in 2026, time may already be running short. Patients who developed gallbladder problems in 2023 or 2024 could be approaching their deadline depending on their state.
Contact an attorney now rather than later to get a free case evaluation and confirm your deadline.
Ozempic MDL and Gallbladder Case Progress
The Ozempic MDL (multidistrict litigation) is the federal judicial mechanism consolidating all Ozempic-related lawsuits into one court. MDL No. 3094, or a similar designation, centralizes pretrial proceedings to avoid duplicating work across hundreds of individual federal cases.
The MDL is housed in the Eastern District of Pennsylvania. Consolidation was ordered by the U.S. Judicial Panel on Multidistrict Litigation (JPML) after the number of individual federal cases exceeded the threshold for efficient management.
As of 2026, the MDL includes claims for gallbladder injuries, gastroparesis, bowel obstruction, and pancreatitis. Gallbladder cases make up a significant portion of the total docket.
MDL progress milestones for 2026:
- Case management orders establishing discovery schedules
- Selection of bellwether cases (representative trials)
- Exchange of expert witness reports between parties
- Daubert hearings to challenge expert testimony
- Pretrial motions on key legal issues
- Possible first bellwether trial in late 2026
Bellwether trials serve as “test runs” for the broader litigation. If plaintiffs win the first few bellwether cases, Novo Nordisk will face enormous pressure to negotiate a global settlement. If defendants win, settlement values could decrease.
The outcome of the MDL will affect every single gallbladder claim in the system.
Ozempic Gallbladder Surgery Compensation Breakdown
Ozempic gallbladder surgery compensation is expected to be the highest category of payouts in this litigation. Surgery cases involve tangible, documented harm that is easy for juries to understand and sympathize with.
Compensation in these cases covers several categories of damages. It is not just about the surgery bill. The law recognizes multiple types of harm when a defective product injures you.
Categories of compensation:
- Medical expenses: Hospital bills, surgery costs, follow-up care, imaging, lab work, and medication
- Lost wages: Time missed from work during surgery, recovery, and follow-up appointments
- Future medical costs: Ongoing digestive treatment, specialist visits, and dietary management
- Pain and suffering: Physical pain from the condition and surgery, plus emotional distress
- Loss of quality of life: Permanent dietary restrictions, chronic digestive issues, and lifestyle changes
- Punitive damages: If a jury finds Novo Nordisk acted with willful disregard for patient safety, punitive damages may be awarded on top of compensatory damages
| Compensation Type | Typical Range |
|---|---|
| Medical expenses | $15,000 to $100,000+ |
| Lost wages | $5,000 to $50,000 |
| Pain and suffering | $50,000 to $300,000 |
| Future medical costs | $10,000 to $75,000 |
| Punitive damages (if awarded) | Varies widely |
The strongest cases will combine several of these categories. A patient who missed three months of work, paid $80,000 in medical bills, and now lives with chronic digestive problems has a much more valuable case than someone who had a routine laparoscopic surgery and recovered in two weeks.
Key Takeaway: Ozempic gallbladder surgery compensation covers far more than just the hospital bill, and patients with documented complications, lost income, and ongoing health problems stand to receive the largest payouts.
Frequently Asked Questions
How much money can I get from an Ozempic gallbladder lawsuit?
Most estimates range from $50,000 to $500,000 depending on injury severity.
Cases involving gallbladder removal with complications are projected at the higher end.
No settlements have been finalized yet, so these are attorney projections based on similar pharmaceutical litigation.
What is the deadline to file an Ozempic gallbladder lawsuit in 2026?
The deadline depends on your state’s statute of limitations, which is typically two to three years from when you discovered Ozempic caused your injury.
If your gallbladder problems started in 2023 or 2024, your window may be closing soon.
Contact an attorney immediately to confirm your specific deadline.
Does Ozempic actually cause gallbladder problems?
Clinical studies have shown that semaglutide increases the risk of gallstones and gallbladder inflammation.
GLP-1 drugs slow gallbladder motility, and rapid weight loss further raises gallstone risk.
The FDA’s adverse event database contains thousands of gallbladder reports linked to Ozempic and Wegovy.
Can I still file an Ozempic lawsuit if I had my gallbladder removed years ago?
It depends on when you took Ozempic relative to the surgery.
If you had your gallbladder removed before ever taking Ozempic, you likely do not qualify.
If you took Ozempic and the gallbladder removal happened afterward, you may have a strong claim.
Is the Ozempic gallbladder lawsuit a class action or mass tort?
The Ozempic gallbladder lawsuit is a mass tort, not a class action.
Each person’s case is evaluated individually based on their specific injuries and evidence.
This means your payout reflects your actual harm, not a flat amount shared by everyone.
The Ozempic gallbladder lawsuit is gaining momentum as 2026 brings bellwether trial preparations and growing case numbers. If you took Ozempic and suffered gallbladder disease or surgery, now is the time to act.
Gather your medical records. Check your state’s filing deadline. Talk to a qualified attorney about your case.
Waiting too long could cost you your right to compensation. The evidence is building, the courts are moving, and your window to file may be shorter than you think.
